Ascend Metoprolol Succinate 25mg Tablets: Failed Dissolution Risk
Ascend Laboratories recalls 25mg metoprolol succinate extended-release tablets due to failed dissolution specifications. This may affect medication effectiveness. Contact for remedy details.
Lower-risk recall
Failed Dissolution Specifications
Contact the company
What happened, in plain English
Ascend Laboratories is recalling 25mg metoprol:ol succinate extended-release tablets that may not dissolve properly. This could lead to incorrect medication dosing if taken as intended. Read more at govinfonow.com/recall/31331-ascend-metoprolol-succinate-25mg-tablets-failed-dissolution-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/31331-ascend-metoprolol-succinate-25mg-tablets-failed-dissolution-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0547-2026
Cite this page
“Ascend Metoprolol Succinate 25mg Tablets: Failed Dissolution Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31331-ascend-metoprolol-succinate-25mg-tablets-failed-dissolution-risk. Based on FDA recall #D-0547-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0547-2026%22&limit=1).
Why it’s dangerous
The tablets may not dissolve correctly in the stomach, leading to inconsistent medication release. This could cause incorrect dosing levels if taken as intended.
Who’s affected
People prescribed metoprolol succinate 25mg tablets by a doctor. Those with heart conditions or high blood pressure are most at risk.
How to tell if you have this one
Check for the product name 'Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only'. Look for lot number 25140859 and expiration date January 2027 on the packaging.
- Brand
Ascend Laboratories- Category
Drug
What to do — step by step
Check Product Details
Look for lot number 25140859 and expiration date January 2027 on the packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 23 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Ascend Laboratories recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0547-2026 (April 27, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0547-2026 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.